Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study

Published:2021-04 Issue: Volume:105 Page:516-521
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Pandit Anuja,Bhalani Nirav,Bhushan B.L. Shashi,Koradia Parshottam,Gargiya Shweta,Bhomia Vinay,Kansagra Kevinkumar

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference26 articles.

1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19;Bastard;Science,2020

2. Imbalanced host response to SARS-CoV-2 drives development of COVID-19;Blanco-Melo;Cell,2020

3. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis;Cevik;Lancet Microbe,2020

4. The 2019 novel coronavirus disease (COVID-19) pandemic: a zoonotic prospective;Chakraborty;Asian Pac J Trop Med,2020

5. WHO declares COVID-19 a pandemic;Cucinotta;Acta Biomed,2020

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study;Pathogens;2024-06-26

2. Harnessing the power of IFN for therapeutic approaches to COVID-19;Journal of Virology;2024-05-14

3. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond;Seminars in Immunology;2024-03

4. Construction of viral-based expression vectors for high-level production of human interferon alpha 2b in plants;Applied Microbiology and Biotechnology;2024-02-23

5. Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection;Frontiers in Immunology;2024-01-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3